Kepler Trust Intelligence provides research and information for professional and private investors. In order to ensure that we provide you with the right kind of content, and to ensure that the content we provide is compliant, you need to tell us what type of investor you are.Read the full article
A highly experienced management team and a flexible portfolio of quoted and unquoted biotechnology stocks, with a yield target of 4% of NAV...
To achieve long-term capital growth by investing in biotechnology and other life sciences companies
SV Life Sciences Managers LLP
Carl Harald Janson; Kate Bingham; Alisa Craig;
Association of Investment Companies (AIC) Sector
Biotechnology & Healthcare
12 Mo Yield
Dividend Distribution Frequency
Disclosure – Non-Independent Marketing Communication
This is a non-independent marketing communication commissioned by International Biotechnology. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.